Back
Amplify Weight Loss Drug & Treatment ETF Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
23.60
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Amplify Weight Loss Drug & Treatment ETF Price Quote
$23.60
-0.07 (-0.25%)
(Updated: November 27, 2024 at 3:48 PM ET)
Amplify Weight Loss Drug & Treatment ETF Key Stats
Sell
16
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Day range:
$23.60 - $23.70
52-week range:
$22.57 - $28.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.7K
Avg. volume:
2.9K
1-year change:
0%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Amplify Weight Loss Drug & Treatment ETF Make?
Data Unavailable
Is Amplify Weight Loss Drug & Treatment ETF Growing As A Company?
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Stock Price Performance
-
Did Amplify Weight Loss Drug & Treatment ETF Stock Go Up Last Month?
Amplify Weight Loss Drug & Treatment ETF share price went down by -8.71% last month -
Did THNR's Share Price Rise Over The Last Year?
THNR share price rose by 0% over the past 1 year
What Is Amplify Weight Loss Drug & Treatment ETF 52-Week High & Low?
-
What Is Amplify Weight Loss Drug & Treatment ETF’s 52-Week High Share Price?
Amplify Weight Loss Drug & Treatment ETF has traded as high as $28.19 over the past 52 weeks -
What Is Amplify Weight Loss Drug & Treatment ETF’s 52-Week Low Share Price?
Amplify Weight Loss Drug & Treatment ETF has traded as low as $22.57 over the past 52 weeks
Amplify Weight Loss Drug & Treatment ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Amplify Weight Loss Drug & Treatment ETF?
Data Unavailable
Is Amplify Weight Loss Drug & Treatment ETF Cash Flow Positive?
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Return On Invested Capital
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Earnings Date & Stock Price
-
What Is Amplify Weight Loss Drug & Treatment ETF's Stock Price Today?
A single share of THNR can be purchased today for 23.67 -
What Is Amplify Weight Loss Drug & Treatment ETF’s Stock Symbol?
Amplify Weight Loss Drug & Treatment ETF trades on the nysearca under the ticker symbol: THNR -
When Is Amplify Weight Loss Drug & Treatment ETF’s Next Earnings Date?
The next quarterly earnings date for Amplify Weight Loss Drug & Treatment ETF is scheduled on November 28, 2024 -
When Is THNR's next ex-dividend date?
Amplify Weight Loss Drug & Treatment ETF's next ex-dividend date is November 28, 2024 -
How To Buy Amplify Weight Loss Drug & Treatment ETF Stock?
You can buy Amplify Weight Loss Drug & Treatment ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amplify Weight Loss Drug & Treatment ETF Competitors
-
Who Are Amplify Weight Loss Drug & Treatment ETF's Competitors?
Below is a list of companies who compete with Amplify Weight Loss Drug & Treatment ETF or are related in some way:
Amplify Weight Loss Drug & Treatment ETF Dividend Yield
-
What Is THNR Dividend Yield?
Amplify Weight Loss Drug & Treatment ETF’s dividend yield currently is 0% -
What Is Amplify Weight Loss Drug & Treatment ETF’s Payout Ratio?
Amplify Weight Loss Drug & Treatment ETF’s payout ratio is 0% -
When Did Amplify Weight Loss Drug & Treatment ETF Last Pay A Dividend?
The latest dividend pay date is November 28, 2024 -
What Is Amplify Weight Loss Drug & Treatment ETF’s Dividend Per Share?
Amplify Weight Loss Drug & Treatment ETF pays a dividend of $0.00 per share
Amplify Weight Loss Drug & Treatment ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable